Back
Akari Therapeutics PLC Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
14
AKTX
Akari Therapeutics PLC
Last Price:
$0.95
Seasonality Move:
-8.16%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Akari Therapeutics PLC Stock Forecast
-
Is Akari Therapeutics PLC Stock Undervalued?The current Akari Therapeutics PLC [AKTX] share price is $0.97. The Score for AKTX is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
-
AKTX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Akari Therapeutics PLC Stock Go Up Next Year?
Data Unavailable
Akari Therapeutics PLC Stock Rating
Data Unavailable
Akari Therapeutics PLC Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
akaritx.com
52-Week Data
52-Week High:
4.40
52-Week Low:
0.90
Prediction Charts
Market Cap:
24M
Price in USD:
0.97
Volume:
36.7K
Beta:
-0.44
Technical Analysis
SMA50:
1.81
SMA100:
2.58
SMA200:
2.42
52-Wk Change:
-66.97%
Stock Predictions
-
Is Akari Therapeutics PLC stock public?Yes, Akari Therapeutics PLC is a publicly traded company.
-
What is the Akari Therapeutics PLC stock quote today?The Akari Therapeutics PLC stock price is 0.97 USD today.
-
How to buy Akari Therapeutics PLC stock online?You can buy Akari Therapeutics PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-3 | 1.38 | 1.29 | 1.46 | 1.26 |
| Dec-4 | 1.31 | 1.30 | 1.40 | 1.19 |
| Dec-5 | 1.34 | 1.27 | 1.40 | 1.22 |
| Dec-6 | 1.31 | 1.29 | 1.38 | 1.25 |
| Dec-9 | 1.23 | 1.17 | 1.34 | 1.10 |
| Dec-10 | 1.12 | 1.00 | 1.17 | 0.93 |
| Dec-11 | 0.98 | 0.98 | 1.04 | 0.98 |
| Dec-12 | 0.98 | 0.95 | 1.16 | 0.95 |
| Dec-13 | 0.95 | 0.97 | 1.03 | 0.95 |
| Dec-16 | 1.01 | 0.99 | 1.01 | 0.95 |
| Dec-17 | 1.13 | 1.00 | 1.13 | 1.00 |
| Dec-18 | 1.00 | 0.96 | 1.02 | 0.96 |
| Dec-19 | 0.96 | 1.00 | 1.04 | 0.96 |
| Dec-20 | 0.98 | 0.97 | 1.01 | 0.95 |
Akari Therapeutics PLC Earnings
Data Unavailable
Akari Therapeutics PLC Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and a decrease next year of $0.00 per share.
* Akari Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.